Macrogenics Stock Performance
| MGNX Stock | USD 1.83 0.10 5.18% |
On a scale of 0 to 100, MacroGenics holds a performance score of 7. The company secures a Beta (Market Risk) of 0.43, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MacroGenics' returns are expected to increase less than the market. However, during the bear market, the loss of holding MacroGenics is expected to be smaller as well. Please check MacroGenics' downside variance, and the relationship between the total risk alpha and daily balance of power , to make a quick decision on whether MacroGenics' current price movements will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in MacroGenics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, MacroGenics showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | MacroGenics Forms Hammer Chart Pattern Time for Bottom Fishing | 11/10/2025 |
2 | MacroGenics Q3 Earnings and Revenues Surpass Estimates | 11/12/2025 |
3 | MacroGenics, Inc. MGNX Shares Sold by Connor Clark Lunn Investment Management Ltd. | 11/19/2025 |
4 | MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference | 11/25/2025 |
5 | Acquisition by Beth Smith of 25000 shares of MacroGenics at 1.33 subject to Rule 16b-3 | 12/08/2025 |
6 | MacroGenics Stock Passes Below 200 Day Moving Average Heres What Happened | 12/12/2025 |
7 | MacroGenics Insider Ups Holding By 909 percent During Year | 12/18/2025 |
8 | Sanofis Teizeild Gets EU Approval for Treating Type 1 Diabetes | 01/13/2026 |
9 | January 2026s Top Penny Stocks To Watch | 01/27/2026 |
| Begin Period Cash Flow | 101 M | |
| Total Cashflows From Investing Activities | 149.3 M |
MacroGenics | Build AI portfolio with MacroGenics Stock |
MacroGenics Relative Risk vs. Return Landscape
If you would invest 158.00 in MacroGenics on November 1, 2025 and sell it today you would earn a total of 35.00 from holding MacroGenics or generate 22.15% return on investment over 90 days. MacroGenics is currently generating 0.4157% in daily expected returns and assumes 4.2876% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than MacroGenics, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MacroGenics Target Price Odds to finish over Current Price
The tendency of MacroGenics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.83 | 90 days | 1.83 | about 7.07 |
Based on a normal probability distribution, the odds of MacroGenics to move above the current price in 90 days from now is about 7.07 (This MacroGenics probability density function shows the probability of MacroGenics Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days MacroGenics has a beta of 0.43. This indicates as returns on the market go up, MacroGenics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding MacroGenics will be expected to be much smaller as well. Additionally MacroGenics has an alpha of 0.1342, implying that it can generate a 0.13 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). MacroGenics Price Density |
| Price |
Predictive Modules for MacroGenics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MacroGenics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MacroGenics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MacroGenics is not an exception. The market had few large corrections towards the MacroGenics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MacroGenics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MacroGenics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.13 | |
β | Beta against Dow Jones | 0.43 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | 0.02 |
MacroGenics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MacroGenics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MacroGenics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MacroGenics may become a speculative penny stock | |
| MacroGenics had very high historical volatility over the last 90 days | |
| MacroGenics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 148.34 M. Net Loss for the year was (66.97 M) with loss before overhead, payroll, taxes, and interest of (55.85 M). | |
| MacroGenics currently holds about 133.74 M in cash with (68.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 58.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: January 2026s Top Penny Stocks To Watch |
MacroGenics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MacroGenics Stock often depends not only on the future outlook of the current and potential MacroGenics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MacroGenics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 62.6 M | |
| Cash And Short Term Investments | 201.7 M |
MacroGenics Fundamentals Growth
MacroGenics Stock prices reflect investors' perceptions of the future prospects and financial health of MacroGenics, and MacroGenics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MacroGenics Stock performance.
| Return On Equity | -0.81 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (0.59) % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 12.7 M | ||||
| Shares Outstanding | 63.26 M | ||||
| Price To Earning | (4.54) X | ||||
| Price To Book | 1.82 X | ||||
| Price To Sales | 0.96 X | ||||
| Revenue | 148.34 M | ||||
| Gross Profit | (55.85 M) | ||||
| EBITDA | (57.37 M) | ||||
| Net Income | (66.97 M) | ||||
| Cash And Equivalents | 133.74 M | ||||
| Cash Per Share | 2.18 X | ||||
| Total Debt | 37.46 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 3.30 X | ||||
| Book Value Per Share | 1.06 X | ||||
| Cash Flow From Operations | (68.37 M) | ||||
| Earnings Per Share | (1.21) X | ||||
| Market Capitalization | 122.09 M | ||||
| Total Asset | 261.65 M | ||||
| Retained Earnings | (1.17 B) | ||||
| Working Capital | 161.96 M | ||||
| Current Asset | 342.38 M | ||||
| Current Liabilities | 23.29 M | ||||
About MacroGenics Performance
Evaluating MacroGenics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if MacroGenics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MacroGenics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 62.33 | 59.22 | |
| Return On Tangible Assets | (0.29) | (0.31) | |
| Return On Capital Employed | (0.62) | (0.65) | |
| Return On Assets | (0.29) | (0.31) | |
| Return On Equity | (0.66) | (0.70) |
Things to note about MacroGenics performance evaluation
Checking the ongoing alerts about MacroGenics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MacroGenics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MacroGenics may become a speculative penny stock | |
| MacroGenics had very high historical volatility over the last 90 days | |
| MacroGenics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 148.34 M. Net Loss for the year was (66.97 M) with loss before overhead, payroll, taxes, and interest of (55.85 M). | |
| MacroGenics currently holds about 133.74 M in cash with (68.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 58.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: January 2026s Top Penny Stocks To Watch |
- Analyzing MacroGenics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MacroGenics' stock is overvalued or undervalued compared to its peers.
- Examining MacroGenics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MacroGenics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of MacroGenics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MacroGenics' stock. These opinions can provide insight into MacroGenics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for MacroGenics Stock Analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.